Search results

A large group of ANSTO environmental scientists and collaborators have produced the first groundwater stable isotopes, ‘isoscapes’, intuitive maps with grid data, across NSW combining new and pre-existing isotope measurements.

Dr Katie Sizeland, a Postdoctoral Fellow on the Small Angle X-ray Scattering beamline at the Australian Synchrotron, has been chosen for the Homeward Bound STEMM leadership program

An unusual and very exciting form of carbon - that can be created by drawing on paper - looks to hold the key to real-time, high throughput DNA sequencing, a technique that would revolutionise medical research and testing.

ANSTO researchers contribute to study which finds evidence of Aboriginal occupation 65,000 years ago in Northern Australia.

Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.

ANSTO has been licensed as the Australian manufacturing partner of an innovative, non-invasive treatment for non-melanoma skin cancer (NMSC).

Today The Australian ran a story entitled “Fears for indigenous lands as foreign nuclear waste headed our way”, 18 September 2018. ANSTO was not contacted in relation to the article, but can provide the following information in response which can be attributed to a spokesperson.

Nitrogen-doped ultrananocrystalline diamond (N-UNCD) is a promising material for future biological and electrochemical applications.

IAEA Regional Training Course on coastal environments held at ANSTO for representatives from Asian Pacific.

This week ANSTO formally launched the nandin Deep Technology Incubator, a full-service innovation hub that enables the best and the brightest minds to come together to foster innovation and change.

The nandin Deep Technology Incubator at ANSTO’s Lucas Heights innovation precinct has welcomed two new members.

Information about ANSTO’s COVID-19 Rapid Antigen Test Program

ANSTO has contributed to international research on quasicrystals that opens the door to tailored magnetic materials.

A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.

ANSTO has contributed to research on a novel therapeutic option for combatting antimicrobial-resistant Gram-negative bacteria, known as superbugs.